In a recently published study, we documented our experience using platelet-rich plasma (PRP) and concentrated bone marrow mononucleated cells (BMMNCs) for the treatment of musculoskeletal injuries (ligament and tendon overuse injuries) in competition horses refractory to other therapies [1]. We evaluated number of cells and presence of growth factors (GFs) injected, and performed follow-ups on horses weekly, up to one year. The results of our study showed a marked improvement in the degree of lameness, with 84.6% of horses returning to competition, and a direct correlation between number of platelets injected and clinical outcome.

Reply to comments of Carmona et al. to the article: Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses

Kon Elizaveta;
2011

Abstract

In a recently published study, we documented our experience using platelet-rich plasma (PRP) and concentrated bone marrow mononucleated cells (BMMNCs) for the treatment of musculoskeletal injuries (ligament and tendon overuse injuries) in competition horses refractory to other therapies [1]. We evaluated number of cells and presence of growth factors (GFs) injected, and performed follow-ups on horses weekly, up to one year. The results of our study showed a marked improvement in the degree of lameness, with 84.6% of horses returning to competition, and a direct correlation between number of platelets injected and clinical outcome.
MESENCHYMAL STEM-CELLS; PROLIFERATION; THERAPY
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11699/3873
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
social impact